MBLY

Mobileye Global Inc.

$7.30

+1.53% 2026-10-20

Consumer Cyclical

1M 3M 6M 1Y 2Y

MBLYSPY

+4.0%

-9.0%

-18.8%

-7.2%

YTD

-30.1%

-50.3%

Live chart

Loading live chart…

Grades vs sector

Momentum

Not enough data yet

–

Percentile within its GICS sector across the S&P 1500.

Growth

Not enough data yet

–

Percentile within its GICS sector across the S&P 1500.

Value

Not enough data yet

–

Percentile within its GICS sector across the S&P 1500.

Profitability

Not enough data yet

–

Percentile within its GICS sector across the S&P 1500.

Revisions

Not enough data yet

–

30-day change in analysts' current-year EPS estimate; graded across covered stocks.

Our models

Not held by any of our 5 live models right now.

Quality Growth

not ranked (outside this model's universe or screens)

Momentum Top 15

not ranked (outside this model's universe or screens)

Momentum Blend

not in the current book

New Highs Growth

not ranked (outside this model's universe or screens)

Conviction 20

not in the current book

News

More news

ADNT or MBLY: Which Is the Better Value Stock Right Now?

Zacks · Oct 19

Nvidia-Backed Startup doubleAI Launches Model to Pare Cost of Compute

The Wall Street Journal · Oct 19

Mobileye Just Scored a New Bullish Rating. Here's Why.

Barchart · Oct 16

Citi starts Mobileye at Buy, calls it a global leader in vehicle vision

Investing.com · Oct 16

Mobileye Shares Rise 4.3% as Citi Initiates Coverage With Buy Rating and $11 Price Target

InvestorsHub · Oct 16

Key stats

Market cap$6.2B

P/E (trailing)–

P/E (forward)14.9

52-week range6.47 – 15.19

Revenue growth (YoY, latest qtr)+0.4%

Dividend yield0.00%

Analyst consensusBuy (23)

Mean price target$11.19 (+53%)

Valuation and fundamentals

Valuation & fundamentals

Bottom line

Leans undervalued

Model read-out from the numbers below, not advice. Score +2 (DCF counts double).

•DCF (base case)above the price by 10%

▲Piotroski F-score7/9

▲Altman Z3.7 (safe)

▲Analyst target+53% (23 analysts)

Discounted cash flow

Bear

-14%

growth -5% · disc. 11.4% · term. 2.0%

Base

+10%

growth 0% · disc. 10.4% · term. 2.5%

Bull

$10

+41%

growth 3% · disc. 9.4% · term. 3.0%

A DCF starts from trailing free cash flow, so it can overstate value if the last 12 months were unusually strong (or weak). Use the bear case or edit the starting cash flow if so.

Reverse DCFfor context, not a signal

Today's price implies shrinking cash flows: about -1% a year for 10 years.

Implied

-1%/yr

FCF, last 3 yrs

+6%/yr

FCF, last 5 yrs

+24%/yr

Revenue, last 3 yrs

+0%/yr

Revenue, last 5 yrs

+14%/yr

Same inputs as the DCF above: trailing free cash flow 0.4B, 10.4% discount rate, 2.5% growth after year 10, net cash and today's share count. Actual growth rates are compound annual rates from SEC annual filings through FY2025; "n/a" means too little history or a negative starting year.

Edit assumptions · recalculates instantly

Your value per share–

Free cash flow = operating cash flow − capital spending, trailing 12 months (TTM to 2026-06-27). Growth default: average of 3-year revenue CAGR and latest revenue growth, capped at 30%. Years 6–10 fade linearly to terminal growth. Discount rate = 4.25% risk-free assumption + beta 1.24 × 5% equity premium, kept within 7–13%. Bear: lower growth, +1 pt discount, 2% terminal. Bull: higher growth, −1 pt, 3%.

Multiples vs sector

Forward EPS $0.49 vs trailing $-4.97. Forward P/E uses analysts' next-12-month estimate.

Quality & financial health

Gross margin

47.4%

Operating margin

-207.1%

FCF margin

19.2%

Net margin

-201.5%

Return on equity

-49.5%

Return on invested capital

-56.6%

Net debt / EBITDA

–

Current ratio

4.6×

Interest cover

-174.0×

Cash conversion (OCF/NI)

–

Piotroski F-score 7/9 · last two fiscal years

✗ Positive net income✓ Positive operating cash flow✓ Return on assets improved✓ Cash flow above net income✓ Long-term debt / assets fell✗ Current ratio improved✓ No share dilution✓ Gross margin improved✓ Asset turnover improved

Altman Z-score 3.7 (safe zone; above 3.0 = safe, below 1.8 = distress). Not meaningful for banks and insurers.

Analysts

Mean target

$11

+53%

Analysts

Buy

Range

$7–$27

low – high

● price · ◆ mean target

Annual history

FY	Revenue	Net income	Free cash flow
2025	$1.9B	$-392.0M	$523.0M
2024	$1.7B	$-3.1B	$319.0M
2023	$2.1B	$-27.0M	$296.0M
2022	$1.9B	$-82.0M	$435.0M
2021	$1.4B	$-75.0M	$456.0M
2020	$967.0M	$-196.0M	$180.0M

From the company's 10-K filings via SEC XBRL. 3-year revenue CAGR +0.4%.

Earnings

Next report: 2026-10-29 · before open · EPS est 0.10

EstimateActual (beat)Actual (miss)

Report	EPS est	Actual	Surprise
2026-07-23	0.06	0.19	+230.2%
2026-04-23	0.09	0.12	+39.7%
2026-01-22	0.06	0.06	+3.3%
2025-10-23	0.09	0.09	+3.6%
2025-07-24	0.11	0.13	+21.5%
2025-04-24	0.08	0.08	+6.0%
2025-01-30	0.11	0.13	+17.8%
2024-10-31	0.10	0.10	+1.2%

Quarterly revenue

Quarter	Revenue	YoY
2026-06-30	$508.0M	+0.4%
2026-03-31	$558.0M	–
2025-12-31	$446.0M	–
2025-09-30	$504.0M	–
2025-06-30	$506.0M	–

Analyst actions

Evercore ISI Group

2026-10-19 · main

Outperform → Outperform
PT $11

TD Cowen

2026-10-19 · main

Buy → Buy
PT $8

Citigroup

2026-10-16 · init

→ Buy
PT $11

Morgan Stanley

2026-10-15 · main

Equal-Weight → Equal-Weight
PT $9

UBS

2026-10-07 · main

Neutral → Neutral
PT $8

Goldman Sachs

2026-10-06 · main

Neutral → Neutral
PT $8

Insider trades

Yeboah-Amankwah Safroadu

Director · 2026-08-06

BUY
$100.2K

Yeary Frank D

Director · 2026-07-30

BUY
$98.6K

None

None · None

SELL
–

Stats refreshed 2026-10-20 18:14:01 ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now

coteau

Coteau Systematic Strategies publishes stock research and model portfolios. It doesn't manage money or give investment advice. Results are hypothetical unless marked Live. Data: Yahoo Finance (delayed) and SEC EDGAR.

How it works Disclaimer Terms Privacy Data status